ALDEN CANCER THERAPY AS

Operating

Utvikle metoder for behandling av kreft og andre sykdommer for kommersiell utnyttelse samt det som naturlig står i forbindelse med dette.

Forskning og utprøving av metoder for behandling av kreft og andre sykdommer.

Organization

CEO: KH
Karl Henning Kalland1955
Chairman of the board: AH
Anders Haugland1971
Years since formation: 13 years; since Nov 19, 2013
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 112; 1 share class
Total number of shareholders: 5; 4 companies, 1 person
Belongs to group of

Financials

Annual total result 2025: -2,320,895; NOK
Total equity 2025: 1,432,006; NOK

Last update: Jul 20, 2026

Management

Management / administration

Name	Role	Shares
KH Karl Henning Kalland 1955	Managing Director/CEO	17.68 % indirectly

Board

Name	Role	Shares
AH Anders Haugland 1971	Chairman	3.57 % indirectly
KH Karl Henning Kalland 1955	Board Member	17.68 % indirectly
AM Anne Margrete Øyan 1949	Board Member	5.89 % indirectly
SK Stener Kvinnsland 1948	Board Member	3.57 % directly
BT Bjørn Tore Gjertsen 1966	Board Member	23.57 % indirectly

Others

Name	Role	Shares
H HKW NORGE MOMENTUM AS	Auditor	-
R RANDABERG REGNSKAP AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
BT Bjørn Tore Gjertsen 1966	Board Member	23.57 % indirectly
KH Karl Henning Kalland 1955	Managing Director/CEO, Board Member	17.68 % indirectly
AM Anne Margrete Øyan 1949	Board Member	5.89 % indirectly
PB Phillip Benson Keul 1987	-	5.89 % indirectly
TO Tor Ole Rognaldsen 1981	-	3.57 % indirectly
AH Anders Haugland 1971	Chairman	3.57 % indirectly
SK Stener Kvinnsland 1948	Board Member	3.57 % directly

Last update: Jul 2, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
Y YZ HOLDING AS	Ordinary shares	66	58.93 %
V VESTLANDETS INNOVASJONSSELSKAP AS	Ordinary shares	34	30.36 %
O OCEANVIEW VENTURE CAPITAL AS	Ordinary shares	4	3.57 %
M MARCK INVEST AS	Ordinary shares	4	3.57 %
SK Stener Kvinnsland 1948	Ordinary shares	4	3.57 %

Last update: Jun 2, 2025

Group structure

YZ HOLDING AS
Total operating income 2025: NOK 0
Operating profit 2025: NOK -23,530
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	0	0	0	0	0
Annual Total Result	-2,320,895	-1,861,278	-1,853,841	-984,078	-1,250,086
Total assets	1,593,592	1,790,295	2,867,343	2,756,821	3,081,806
Total liabilities	161,585	4,549,303	3,765,073	1,800,710	1,177,617
Total equity	1,432,006	-2,759,007	-897,729	956,111	1,904,189

P&L

Year	2025	2024	2023	2022	2021
Total operating income	0	0	0	0	0
Total operating costs	1,304,209	1,869,969	1,856,407	987,476	1,248,402
Operating result	-1,304,209	-1,869,969	-1,856,407	-987,476	-1,248,402
Financial income/costs	-1,016,686	8,691	2,566	3,398	-1,684
Profit before tax	-2,320,895	-1,861,278	-1,853,841	-984,078	-1,250,086
Total tax & extraordinary income/cost	0	0	0	0	0
Annual Total Result	-2,320,895	-1,861,278	-1,853,841	-984,078	-1,250,086

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	488,000	587,132	744,132	1,191,132	1,638,132
Total current assets	1,105,592	1,203,163	2,123,211	1,565,689	1,443,674
Total assets	1,593,592	1,790,295	2,867,343	2,756,821	3,081,806
Short term debt	161,585	23,106	23,719	59,357	177,617
Long term debt	0	4,526,196	3,741,353	1,741,353	1,000,000
Total liabilities	161,585	4,549,303	3,765,073	1,800,710	1,177,617
Contributed capital	6,632,152	320,684	320,684	320,684	284,684
Retained earnings	-5,200,146	-3,079,691	-1,218,414	635,427	1,619,505
Total equity	1,432,006	-2,759,007	-897,729	956,111	1,904,189
Total equity and liabilities	1,593,592	1,790,295	2,867,343	2,756,821	3,081,806

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

ALDEN CANCER THERAPY AS912 772 438